In connection with the equity investment, the Company has agreed to grant Sanofi an exclusive right of first negotiation with respect to certain VTX3232 program rights.
ModeX Therapeutics Inc., an (NASDAQ: OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief Medical Officer, a newly created position. Dr. Abbadessa has over two ...
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of Hetronifly ...
The US Food and Drug Administration (FDA) has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback